Skip to main content

Table 1 Clinical information of the participating families

From: Noninvasive prenatal diagnosis of monogenic disorders based on direct haplotype phasing through targeted linked-read sequencing

Family

Disease

Gene

Genotypes of the Trios

GA

FF (%)

Mat

Pat

Fetus (Mat/Pat)

F01

β-thalassemia

HBB

c.316-197C>T /N

c.-78A>G/N

N/N

12+4

9.3

F02

β-thalassemia

HBB

c.126_129delCTTT/N

c.126_129delCTTT/N

N/N

20+5

15.9

F03

β-thalassemia

HBB

c.126_129delCTTT/N

c.-78A>G/N

c.126_129delCTTT/c.-78A>G

12+3

15.4

F04

β-thalassemia

HBB

c.316-197C>T /N

c.126_129delCTTT/N

N/c.126_129delCTTT

18

12.1

F05

β-thalassemia

HBB

c.126_129delCTTT/N

c.316-197C>T /N

c.126_129delCTTT/N

13+6

20.6

F06

β-thalassemia

HBB

c.216_217insA/T/N

c.126_129delCTTT/N

c.216_217insA/T/ c.126_129delCTTT

13+2

26.8

F07

β-thalassemia

HBB

c.79G>A/N

c.126_129delCTTT/N

N/c.126_129delCTTT

11+3

12.3

F08

β-thalassemia

HBB

c.126_129delCTTT/N

c.316-197C>T/N

c.126_129delCTTT/N

12+3

16.5

F09

β-thalassemia

HBB

c.52A>T/N

c.84_85insC/N

c.52A>T/N

12+1

27.7

F10

β-thalassemia

HBB

c.126_129delCTTT/N

c.79G>A/N

c.126_129delCTTT/c.79G>A

11+1

17.7

F11

β-thalassemia

HBB

c.126_129delCTTT/N

c.126_129delCTTT/N

c.126_129delCTTT/c.126_129delCTTT

17

8.1

F12

β-thalassemia

HBB

c.126_129delCTTT/N

c.126_129delCTTT/N

N/c.126_129delCTTT

17

9.7

F13

α-thalassemia

HBA

- -SEA/N

- -SEA/N

- -SEA/- -SEA

13+3

15.7

F14

α-thalassemia

HBA

- -SEA/N

- -SEA/N

N/N

11+6

13.7

F15

α-thalassemia

HBA

- -SEA/N

- -SEA/N

N/- -SEA

12+4

17.5

F16

α-thalassemia

HBA

- -SEA/N

- -SEA/N

- -SEA/- -SEA

11+3

23.5

F17

α-thalassemia

HBA

- -SEA/N

c.369C>G/N

- -SEA/c.369C>G

18

6.7

F18

MMA

MMACHC

c.609G>A/N

c.609G>A/N

c.609G>A/N

19

16.5

F19

MMA

MMACHC

c.656-658delAGA/N

c.609G>A/N

N/c.609G>A

18

14.2

F20

MMA

MMACHC

c.609G>A/N

c.656-658delAGA/N

N/N

16

12.8

F21

MMA

MMACHC

c.656-658delAGA/N

c.609G>A/N

N/N

17

10.4

F22

MMA

MMACHC

c.80A>G/N

c.609G>A/N

c.80A>G/N

17

10.2

F23

MMA

MMACHC

c.609G>A/N

c.441TG[2]/N

c.609G>A/c.441TG[2]

17

10.1

F24

MMA

MMACHC

c.609G>A/N

c.609G>A/N

N/N

18

17.8

F25

MMA

MMACHC

c.80A>G/N

c.609G>A/N

N/N

17

13.7

F26

MMA

MMACHC

c.609G>A/N

c.658-660delAAG/N

c.609G>A/c.658-660delAAG

17

9.8

F27

MMA

MMACHC

c.609G>A/N

c.445-446delTG/N

N/N

17

10.4

F28

MMA

MMACHC

c.482G>A/N

c.445-446delTG/N

N/N

17

8.2

F29

MMA

MMACHC

c.315C>G/N

c.609G>A/N

c.315C>G/N

16

6.5

F30

MMA

MMACHC

c.609G>A/N

c.609G>A/N

N/N

17+5

8.0

F31

PKU

PAH

c.1197A>T/N

c.764T>C/N

c.1197A>T/c.764T>C

18

7.3

F32

PKU

PAH

c.992T>C/N

c.770G>T/N

N/c.770G>T

17

7.5

F33

PKU

PAH

c.1045T>G/N

c.728G>A/N

N/N

18

11.3

F34

PKU

PAH

c.728G>A/N

c.611A>G/N

N/N

20

5.9

F35

PKU

PAH

c.977G>A/N

c.1238G>C/N

c.977G>A/N

17

21.2

F36

PKU

PAH

c.473G>A/N

c.208_210delTCT

c.473G>A/c.208_210delTCT

18

12.8

F37

PKU

PAH

c.1223G>A/N

c.727C>T/N

N/N

12

8.5

F38

PKU

PAH

c.728G>A/N

c.721C>T/N

c.728G>A/c.721C>T

12

7.2

F39

ARPKD

PKHD1

c.11042T>G/N

c.5137G>T /N

N/c.5137G>T

12+6

15.0

F40

DFNB1A

GJB2

c.235delC/N

c.299-300delAT/N

c.235delC/N

13+1

15.3

  1. FF fetal fraction, GA gestational age, N Normal, PKU phenylketonuria, MMA methylmalonic academia, ARPKD autosomal recessive polycystic kidney disease, DFNB1A autosomal recessive deafness-1A